Rajan Sharma
Stock Analyst at Goldman Sachs
(0.05)
# 4,496
Out of 5,161 analysts
5
Total ratings
25%
Success rate
-50.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $20.06 | -63.86% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $192.50 | -49.61% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $54.28 | -13.41% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $31.04 | +154.51% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $20.06
Upside: -63.86%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $192.50
Upside: -49.61%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $54.28
Upside: -13.41%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $31.04
Upside: +154.51%